SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is drawing attention after a sharp rally that traders say is outpacing other major cryptocurrencies. Bulls see a breakout, while skeptics question the moves low volume and warn that gains may not hold.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFis rollout of SoFiUSD stablecoin settlement across Mastercards payment network is the main catalyst, with traders weighing its potential to expand SoFis payments business against the stocks muted reaction. Many are frustrated that shares gave back early gains and blame persistent selling or short pressure, while bullish traders view the partnership as a longer-term opportunity.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs sharp rally and breakout toward $200 have fueled bullish momentum chatter, with traders citing the FAAs AI air-traffic system rollout as a possible avenue for future Palantir worknot a confirmed new contract. Bulls celebrate the stocks relative strength and dismiss Michael Burrys bearish stance, while skeptics point to its high valuation and the risks of sentiment-driven gains.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

The USITC instituted a Section 337 investigation into Netlists allegations that Micron DRAM products and related systems infringe its patents, with HPE, Lenovo and Super Micro also named as respondents. Traders largely welcomed the move as added leverage for a possible licensing deal, while some noted that the investigation is not a finding of infringement and a settlement is uncertain.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Stronger-than-expected economic activity and inflation concerns pushed Treasury yields higher and revived expectations for further Fed rate hikes, weighing on QQQs growth-heavy holdings. Traders are split between warnings that elevated yields could drive further downside and dip-buyers pointing to repeated rebounds and the indexs resilience.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Edgewater Researchs warning that AppLovins MAX ad network may be nearing a growth ceiling, with competition pressuring revenue spreads, is driving concern about a slowdown. Many traders dismiss the note and view the selloff as a buying opportunity, pointing to Citis report of accelerating e-commerce client growth; others remain wary of competitive and growth risks.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Bitcoins volatile rebound and repeated attempts to break resistance are driving attention, with bullish traders pointing to momentum and short covering while skeptics warn the move may fade. The debate also reflects uncertainty around crypto regulation and interest-rate risks.

Realty Income Corp. is a real estate company, which engages in generating dependable monthly cash dividends from a consistent and predictable level of cash flow from operations. The company was founded by William E. Clark, Jr. and Evelyn Joan Clark in 1969 and is headquartered in San Diego, CA.

Realty Income Corp.

Realty Income is drawing attention amid a sharp decline that traders largely attribute to rising Treasury yields and rate-hike expectations weighing on income-focused REITs; some also point to share issuance. Dividend-focused investors are buying the dip for its higher yield, while others warn the slide could continue as Treasuries compete for income-seeking capital.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Vikings proposed stock-and-convertible-note offering after encouraging VK2735 maintenance-study results has sparked debate: some traders see dilution and a setback to momentum, while others view the financing as support for Phase 3 development and stronger negotiating leverage; buyout or partnership talk remains speculative.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Muses early adoption and Meta Connects AI, smart-glasses and VR announcements are driving attention. Bulls see a consumer AI opportunity through Metas large platforms, while skeptics question monetization, privacy and whether the product news is already priced in.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CERo Therapeutics Gets Fast Track Designation For Experimental Cancer Drug, But Stock Tumbles – Here’s What Happened

Equity

The new designation was granted weeks after the FDA awarded the experimental drug an Orphan Drug designation.


Cero Therapeutics Rockets On FDA Orphan Drug Status For Blood Cancer Drug; Retail Bulls Feel Stock 'Still Has A Few Pumps Left'

CER-1236 is designed to engineer T cells with phagocytic, or target-cell "eating," functions alongside traditional cancer-killing mechanisms. 

CERo Therapeutics Partners With University Of California Davis For Manufacturing Lead Compound For Treating Cancer: Retail Stays Bullish

The compound will be used in the company’s Phase 1 clinical trial for Acute Myeloid Leukemia, with the first patient expected to be dosed in the first half of 2025.

Top 5 Biotech Stocks That Captured Retail Investor Interest The Most In 2024

Despite their stock price struggles, these companies have captivated retail investors with groundbreaking therapies and promising clinical developments.

This account has been verified as an official CERO representative.

Verified Account

CERo Therapeutics

Phoenix Biotech Acquisition is a blank-check company that operates for the purpose of completing mergers, acquisitions, or similar transactions. It focuses on identifying and combining with businesses in the biotechnology sector. The company actively seeks potential targets for business combinations.

CERo Therapeutics Holdings Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

CERo Therapeutics Holdings Inc

$CERO I went ahead and picked up another 14K shares.  I understand that this and some of my other investments are long plays, but I'm patient and have conviction they will play out.  $SRXH $QBTS

Kenneth Pearce

$CERO  ,  If cero unable to paid loan on october 2026 , that will allow a hostile take over by SRXH ?         pipeline of cero at phase 1 and even good outcome  to push $0.30 ish .., !  
any  bullish case for $30

HerreMerre

$CERO Consensus Price Target 
$30.00 
243,802.44% Upside 
According to the 3 analysts' twelve-month price targets for CERo Therapeutics, the average price target is $30.00. The highest price target for CERO is $30.00, while the lowest price target for CERO is $30.00. The average price target represents a forecasted upside of 243,802.44% from the current price of $0.01. 
-Source (Market Beat)  
.... I would be happy with 50 cents

$CERO How so? 
They simply take ownership of the drug IP. If that happens, shareholders are left holding an empty corporate shell with virtually no asset value. 
 
If the allow, Cero could push 4 times with a 30-day extention and then we would be into 2027. 
 
for anyone down 90% and more this is a dead cat, they need a private takeover offer.

$CERO the only reason for $SRXH to take all this credit on CERO would be to dump their data and merge something into the shell. But their own stock performance is so bad maybe worst in the market who wants to give them another bullet and gun ?

Feed

News

Sentiment

Fundamentals

Info

CERO CERo Therapeutics Holdings Inc

Fundamentals

Latest CERO News